Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecfidera
Pharma
Biogen places chips behind 4 new drugs as MS competition mounts
As multiple sclerosis generic competition heats up, Biogen is putting its chips behind four new drugs: Leqembi, Skyclarys, Qalsody and Zurzuvae.
Fraiser Kansteiner
Feb 12, 2025 11:35am
Biogen raises profit guidance as Leqembi's launch trudges on
Oct 30, 2024 12:30pm
Health plan sues Biogen for alleged Tecfidera kickbacks scheme
Aug 21, 2024 11:34am
Biogen CEO plots turnaround after 'weak' 2023 performance
Feb 13, 2024 11:28am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
Biogen scores a Tecfidera patent win in Europe
May 5, 2023 11:02am
